22 phenotypes from 4 alleles in 5 genetic backgrounds

Allelic Composition Genetic Background	Annotated Term	Reference
Plcg1tm1Gcrp/Plcg1tm1Gcrp involves: 129S1/Sv * 129X1/SvJ * C57BL/6	embryonic growth arrest	J:39281
	embryonic growth retardation	J:39281
	embryonic lethality during organogenesis, complete penetrance	J:39281
Plcg1tm1Gcrp/Plcg1tm1Rwen Tg(Cd4-cre)1Cwi/0 either: B6.Cg-Plcg1tm1Gcrp/Plcg1tm1Rwen Tg(Cd4-cre)1Cwi or (involves: 129X1/SvJ * C57BL/6 * DBA/2)	abnormal T cell activation	J:157757
	alopecia	J:157757
	decreased body size	J:157757
	decreased body weight	J:157757
	decreased regulatory T cell number	J:157757
	decreased T cell number	J:157757
	dermatitis	J:157757
	ear inflammation	J:157757
	increased anti-double stranded DNA antibody level	J:157757
	increased CD4-positive, alpha-beta T cell number	J:157757
	increased T cell proliferation	J:157757
	rectal prolapse	J:157757
	skin inflammation	J:157757
Plcg1tm1Ine/Plcg1tm1Ine involves: 129P2/OlaHsd	abnormal embryonic hematopoiesis	J:73254
	embryonic lethality during organogenesis, complete penetrance	J:73254
Plcg1tm2Gcrp/Plcg1tm2Gcrp involves: 129/Sv * CD-1	abnormal embryonic hematopoiesis	J:75316
	abnormal proerythroblast morphology	J:75316
	abnormal vascular endothelial cell development	J:75316
	abnormal vasculogenesis	J:75316
	absent visceral yolk sac blood islands	J:75316
	embryonic lethality during organogenesis, complete penetrance	J:75316
Plcg1tm2Gcrp/Plcg1tm2Gcrp involves: 129S6/SvEvTac * C57BL/6	embryonic growth arrest	J:39281
	embryonic growth retardation	J:39281
	embryonic lethality, complete penetrance	J:39281